Brief: Lipigon Pharmaceuticals Rights Issue Generates Proceeds Of SEK 29.3 Mln
April 26 (Reuters) - Lipigon Pharmaceuticals AB LPGO.ST :
* ANNOUNCES RESULTS OF RIGHTS ISSUE
* SUBSCRIPTION RATE IN RIGHTS ISSUE WAS 82.8%
* RAISES PROCEEDS OF SEK 29.3 MILLION BEFORE ISSUE COSTS
Source text for Eikon: ID:nBQNbBQ0yd
Further company coverage: LPGO.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Lipigon Pharmaceuticals AB
See all newsBrief: Nasdaq To Delist Lipigon Pharmaceuticals From First North Growth Market
Brief: Lipigon Expected To Be Removed From Trading On Nasdaq Stockholm On May 18
Brief: Lipigon Proposes To Delist Company From Nasdaq First NGM
Brief: Lipigon Pharmaceuticals Oct-Dec Oper Loss At SEK 7.2 Mln
Brief: Lipigon Pharmaceuticals Aims To Reduce Cost Base By Two-Thirds